About APT Medical Inc. Company

The company is a high-tech enterprise focusing on R&D, production and sales of cardiac electrophysiology and interventional medical devices. It has formed a business layout dominated by complete coronary access and cardiac electrophysiological medical devices, with peripheral vascular interventional medical devices as the main development direction. It was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on January 7, 2021. The stock abbreviation is “Huitai Healthcare”, and the stock code is “688617.” The company is a high-tech enterprise focusing on R&D, production and sales of electrophysiological and interventional medical devices. It is one of the enterprises with a complete range of domestic electrophysiological and vascular interventional medical devices, leading in scale, and strong market competitiveness. It already has the ability to form strong competition with foreign products. The company's marketed products include electrophysiology, coronary access, peripheral vascular intervention, and non-vascular interventional medical devices. The company won the title of national specialty, specialty and new “little giant” enterprise in 2020; Hunan Ept won the title of national key specialty, specialty and new “little giant” enterprise in 2021.